| CYSB2300202 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-10-31 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2200053 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| JYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-16 | | | | | view |
| CXSL2101163 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-30 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2101317 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2022-01-05 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2101320 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Supplementary Application | 2021-12-31 | | TOT Biopharm Co Ltd | | | view |
| CXSL2101219 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-07-27 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2300063 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-03-23 | | Shandong BoAn Biotechnology Co Ltd | | | view |
| CXSS2200040 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2022-04-22 | | SinoCelltech Ltd | | | view |
| CXSL2400202 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-03-23 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2101108 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2021-07-13 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2300112 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-06-12 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JXSL2200084 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-06-13 | | | | | view |
| CYSB2200097 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2022-03-25 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2200055 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2300174 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-09-26 | | TOT Biopharm Co Ltd | | | view |
| CYSB2200057 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2101115 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2021-07-14 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| JXSL2200098 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Import Drug Application | 2022-07-02 | | | | | view |
| CYSB2101321 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Supplementary Application | 2021-12-31 | | TOT Biopharm Co Ltd | | | view |
